Laser Clinic S.C
Welcome,         Profile    Billing    Logout  
 0 Trials 
3 Trials

   

Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Olechowicz, Joanna
EMBARQ-CSU1, NCT06445023: A Phase 3 Study of Barzolvolimab in Participants With Chronic Spontaneous Urticaria

Recruiting
3
915
Europe, Canada, US, RoW
barzolvolimab, Matching placebo
Celldex Therapeutics
Chronic Spontaneous Urticaria
10/26
04/27
Matusiak, Katarzyna
EMBARQ-CSU1, NCT06445023: A Phase 3 Study of Barzolvolimab in Participants With Chronic Spontaneous Urticaria

Recruiting
3
915
Europe, Canada, US, RoW
barzolvolimab, Matching placebo
Celldex Therapeutics
Chronic Spontaneous Urticaria
10/26
04/27
Szulc, Paulina
EMBARQ-CSU1, NCT06445023: A Phase 3 Study of Barzolvolimab in Participants With Chronic Spontaneous Urticaria

Recruiting
3
915
Europe, Canada, US, RoW
barzolvolimab, Matching placebo
Celldex Therapeutics
Chronic Spontaneous Urticaria
10/26
04/27
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Olechowicz, Joanna
EMBARQ-CSU1, NCT06445023: A Phase 3 Study of Barzolvolimab in Participants With Chronic Spontaneous Urticaria

Recruiting
3
915
Europe, Canada, US, RoW
barzolvolimab, Matching placebo
Celldex Therapeutics
Chronic Spontaneous Urticaria
10/26
04/27
Matusiak, Katarzyna
EMBARQ-CSU1, NCT06445023: A Phase 3 Study of Barzolvolimab in Participants With Chronic Spontaneous Urticaria

Recruiting
3
915
Europe, Canada, US, RoW
barzolvolimab, Matching placebo
Celldex Therapeutics
Chronic Spontaneous Urticaria
10/26
04/27
Szulc, Paulina
EMBARQ-CSU1, NCT06445023: A Phase 3 Study of Barzolvolimab in Participants With Chronic Spontaneous Urticaria

Recruiting
3
915
Europe, Canada, US, RoW
barzolvolimab, Matching placebo
Celldex Therapeutics
Chronic Spontaneous Urticaria
10/26
04/27

Download Options